CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Total revenues		$ 37,823	$ 43,668	$ 79,968	$ 79,640
Total costs of revenues		17,847	22,745	37,316	44,726
Gross profit		19,976	20,923	42,652	34,914
Operating expenses:
Sales and marketing		2,421	3,539	7,040	6,973
Research and development		848	2,011	2,133	3,769
General and administrative		12,765	12,880	23,774	24,347
Depreciation and amortization		1,736	4,700	3,347	9,936
Stock-based compensation		1,058	1,088	2,047	2,462
Impairment of goodwill, intangible assets, and other long-lived assets		8,246	0	8,741	6,249
Acquisition, integration, and transformation costs		3,644	6,749	7,090	9,133
Total operating expenses		30,718	30,967	54,172	62,869
Loss from operations		(10,742)	(10,044)	(11,520)	(27,955)
Other expense:
Interest expense		(7,136)	(6,603)	(13,994)	(13,598)
Other income, net, including interest income		126	1,950	127	6,858
Total other expense		(7,010)	(4,653)	(13,867)	(6,740)
Loss before income tax benefit (expense)		(17,752)	(14,697)	(25,387)	(34,695)
Income tax benefit (expense)		(867)	2,232	(867)	4,525
Net loss		(18,619)	(12,465)	(26,254)	(30,170)
Less: net income (loss) attributable to noncontrolling interests		508	(27)	956	(287)
Net loss attributable to UpHealth, Inc.		$ (19,127)	$ (12,438)	$ (27,210)	$ (29,883)
Net loss per share attributable to UpHealth, Inc.:
Basic (in dollars per share)		$ (1.05)	$ (0.86)	$ (1.60)	$ (2.07)
Diluted (in dollars per share)		$ (1.05)	$ (0.86)	$ (1.60)	$ (2.07)
Weighted average shares outstanding:
Basic (in shares)	[1]	18,220	14,462	16,975	14,458
Diluted (in shares)	[1]	18,220	14,462	16,975	14,458
Services
Total revenues		$ 31,087	$ 28,096	$ 62,028	$ 53,782
Total costs of revenues		14,954	16,232	28,698	31,990
Licenses and subscriptions
Total revenues		2,852	6,812	4,788	8,593
Total costs of revenues		403	217	722	450
Products
Total revenues		3,884	8,760	13,152	17,265
Total costs of revenues		$ 2,490	$ 6,296	$ 7,896	$ 12,286

[1] Amounts as of June 30, 2022 and before that date differ from those published in our prior condensed consolidated financial statements as they were retrospectively adjusted as a result of the Reverse Stock Split (as described below in Note 1, Organization and Business). Specifically, the number of common shares outstanding during periods before the Reverse Stock Split are divided by the exchange ratio of 10:1, such that each ten shares of common stock were combined and reconstituted into one share of common stock effective December 8, 2022.